Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 1/2017

05-07-2016

Evaluation and reporting of quality of life outcomes in phase III chemotherapy trials for poor prognosis malignancies

Auteurs: M. E. Hamaker, K. J. Schulkes, D. ten Bokkel Huinink, B. C. van Munster, L. H. van Huis, F. van den Bos

Gepubliceerd in: Quality of Life Research | Uitgave 1/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background

Quality of life (QoL) should be included in trials where treatment is expected to have a limited impact on long-term survival. We set out to determine whether phase III chemotherapy trials addressing solid malignancies with a poor prognosis include QoL as a study objective and to assess the extent to which these data have been published.

Methods

We performed a search of the National Institutes of Health clinical trial registry website to identify phase III chemotherapy trials for poor prognosis solid malignancies. The retrieved protocols were subsequently reviewed, to assess whether QoL was included as an outcome measure. Subsequently, a Medline, Embase and world-wide-web search was performed to identify any full text publication or conference abstract regarding the outcome of trials including QoL, which were then reviewed to determine whether and to what extend quality of life results were included.

Results

For the 201 included studies, we found that 57 % of trials did not include QoL as a study objective. Of the remaining trials, 50 % have not reported the QoL results in a full text publication, or presented these only as a single sentence statement.

Conclusion

Evaluation and publication of QoL results of phase III chemotherapy trials for poor prognosis solid malignancies remains limited. This must be improved in order to provide patients suffering from these malignancies with adequate information regarding the benefits and risks of the treatment in terms of both prolongation and quality of life.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference World Health Organisation website on Palliative care. 12-2-2015. World Health Organisation website on Palliative care. 12-2-2015.
2.
go back to reference Brundage, M., Bass, B., Davidson, J., et al. (2011). Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers. Quality of Life Research, 20, 653–664. CrossRefPubMed Brundage, M., Bass, B., Davidson, J., et al. (2011). Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers. Quality of Life Research, 20, 653–664. CrossRefPubMed
3.
go back to reference Aaronson, N. K., Ahmedzai, S., Bergman, B., et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376. CrossRefPubMed Aaronson, N. K., Ahmedzai, S., Bergman, B., et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376. CrossRefPubMed
5.
go back to reference Schlenk, E. A., Erlen, J. A., Dunbar-Jacob, J., et al. (1998). Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Quality of Life Research, 7, 57–65. CrossRefPubMed Schlenk, E. A., Erlen, J. A., Dunbar-Jacob, J., et al. (1998). Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Quality of Life Research, 7, 57–65. CrossRefPubMed
6.
go back to reference Quality of life and clinical trials. Lancet 1995; 346, 1–2. Quality of life and clinical trials. Lancet 1995; 346, 1–2.
7.
go back to reference Speight, J., & Barendse, S. M. (2010). FDA guidance on patient reported outcomes. BMJ, 340, c2921. CrossRefPubMed Speight, J., & Barendse, S. M. (2010). FDA guidance on patient reported outcomes. BMJ, 340, c2921. CrossRefPubMed
8.
go back to reference Fayers, P. M., Hopwood, P., Harvey, A., Girling, D. J., Machin, D., & Stephens, R. (1997). Quality of life assessment in clinical trials–guidelines and a checklist for protocol writers: The U.K. medical research council experience. MRC cancer trials office. European Journal of Cancer, 33, 20–28. CrossRefPubMed Fayers, P. M., Hopwood, P., Harvey, A., Girling, D. J., Machin, D., & Stephens, R. (1997). Quality of life assessment in clinical trials–guidelines and a checklist for protocol writers: The U.K. medical research council experience. MRC cancer trials office. European Journal of Cancer, 33, 20–28. CrossRefPubMed
9.
go back to reference Hamaker, M. E., Stauder, R., & van Munster, B. C. (2014). Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry. Oncologist, 19, 1069–1075. CrossRefPubMedPubMedCentral Hamaker, M. E., Stauder, R., & van Munster, B. C. (2014). Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry. Oncologist, 19, 1069–1075. CrossRefPubMedPubMedCentral
10.
go back to reference Kim, M. K., Lee, J. L., Hyun, M. S., et al. (2008). Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer. Japanese Journal of Clinical Oncology, 38, 64–70. CrossRefPubMed Kim, M. K., Lee, J. L., Hyun, M. S., et al. (2008). Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer. Japanese Journal of Clinical Oncology, 38, 64–70. CrossRefPubMed
11.
go back to reference Wildiers, H., Mauer, M., Pallis, A. et al. (2013). End points and trial design in geriatric oncology research: A joint European organisation for research and treatment of cancer-Alliance for Clinical Trials in Oncology-International Society of Geriatric Oncology position article. Journal of Clinical Oncology, 31(29), 3711–3718 CrossRefPubMed Wildiers, H., Mauer, M., Pallis, A. et al. (2013). End points and trial design in geriatric oncology research: A joint European organisation for research and treatment of cancer-Alliance for Clinical Trials in Oncology-International Society of Geriatric Oncology position article. Journal of Clinical Oncology, 31(29), 3711–3718 CrossRefPubMed
12.
go back to reference Chouliara, Z., Miller, M., Stott, D., Molassiotis, A., Twelves, C., & Kearney, N. (2004). Older people with cancer: perceptions and feelings about information, decision-making and treatment–a pilot study. European Journal of Oncology Nursing, 8, 257–261. CrossRefPubMed Chouliara, Z., Miller, M., Stott, D., Molassiotis, A., Twelves, C., & Kearney, N. (2004). Older people with cancer: perceptions and feelings about information, decision-making and treatment–a pilot study. European Journal of Oncology Nursing, 8, 257–261. CrossRefPubMed
13.
go back to reference Kiebert, G. M., Stiggelbout, A. M., Kievit, J., Leer, J. W., van de Velde, C. J., & de Haes, H. J. (1994). Choices in oncology: factors that influence patients’ treatment preference. Quality of Life Research, 3, 175–182. CrossRefPubMed Kiebert, G. M., Stiggelbout, A. M., Kievit, J., Leer, J. W., van de Velde, C. J., & de Haes, H. J. (1994). Choices in oncology: factors that influence patients’ treatment preference. Quality of Life Research, 3, 175–182. CrossRefPubMed
14.
go back to reference van Bekkum, M. L., van Munster, B. C., Thunnissen, P. L., Smorenburg, C. H., & Hamaker, M. E. (2015). Current palliative chemotherapy trials in the elderly neglect patient-centred outcome measures. Journal of Geriatric Oncology, 6, 15–22. CrossRefPubMed van Bekkum, M. L., van Munster, B. C., Thunnissen, P. L., Smorenburg, C. H., & Hamaker, M. E. (2015). Current palliative chemotherapy trials in the elderly neglect patient-centred outcome measures. Journal of Geriatric Oncology, 6, 15–22. CrossRefPubMed
15.
go back to reference Hamaker, M. E., Stauder, R., & van Munster, B. C. (2014). On-going clinical trials for elderly patients with a hematological malignancy: Are we addressing the right end points? Annals of Oncology, 25, 675–681. CrossRefPubMedPubMedCentral Hamaker, M. E., Stauder, R., & van Munster, B. C. (2014). On-going clinical trials for elderly patients with a hematological malignancy: Are we addressing the right end points? Annals of Oncology, 25, 675–681. CrossRefPubMedPubMedCentral
16.
go back to reference Efficace, F., Bottomley, A., Osoba, D., et al. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology, 21, 3502–3511. CrossRefPubMed Efficace, F., Bottomley, A., Osoba, D., et al. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology, 21, 3502–3511. CrossRefPubMed
19.
go back to reference Hopwood, P., Stephens, R. J., & Machin, D. (1994). Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial. Quality of Life Research, 3, 339–352. CrossRefPubMed Hopwood, P., Stephens, R. J., & Machin, D. (1994). Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial. Quality of Life Research, 3, 339–352. CrossRefPubMed
20.
go back to reference de Kort, S. J., Willemse, P. H., Habraken, J. M., de Haes, H. C., Willems, D. L., & Richel, D. J. (2006). Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials. European Journal of Cancer, 42, 835–845. CrossRefPubMed de Kort, S. J., Willemse, P. H., Habraken, J. M., de Haes, H. C., Willems, D. L., & Richel, D. J. (2006). Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials. European Journal of Cancer, 42, 835–845. CrossRefPubMed
21.
go back to reference Zikos, E., Ghislain, I., Coens, C., et al. (2014). Health-related quality of life in small-cell lung cancer: A systematic review on reporting of methods and clinical issues in randomised controlled trials. Lancet Oncology, 15, e78–e89. CrossRefPubMed Zikos, E., Ghislain, I., Coens, C., et al. (2014). Health-related quality of life in small-cell lung cancer: A systematic review on reporting of methods and clinical issues in randomised controlled trials. Lancet Oncology, 15, e78–e89. CrossRefPubMed
22.
go back to reference Osborne, T. R., Ramsenthaler, C., Siegert, R. J., Edmonds, P. M., Schey, S. A., & Higginson, I. J. (2012). What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools. European Journal of Haematology, 89, 437–457. CrossRefPubMed Osborne, T. R., Ramsenthaler, C., Siegert, R. J., Edmonds, P. M., Schey, S. A., & Higginson, I. J. (2012). What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools. European Journal of Haematology, 89, 437–457. CrossRefPubMed
23.
go back to reference Blazeby, J. M., Avery, K., Sprangers, M., Pikhart, H., Fayers, P., & Donovan, J. (2006). Health-related quality of life measurement in randomized clinical trials in surgical oncology. Journal of Clinical Oncology, 24, 3178–3186. CrossRefPubMed Blazeby, J. M., Avery, K., Sprangers, M., Pikhart, H., Fayers, P., & Donovan, J. (2006). Health-related quality of life measurement in randomized clinical trials in surgical oncology. Journal of Clinical Oncology, 24, 3178–3186. CrossRefPubMed
24.
Metagegevens
Titel
Evaluation and reporting of quality of life outcomes in phase III chemotherapy trials for poor prognosis malignancies
Auteurs
M. E. Hamaker
K. J. Schulkes
D. ten Bokkel Huinink
B. C. van Munster
L. H. van Huis
F. van den Bos
Publicatiedatum
05-07-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 1/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1360-0